Gerresheimer’s Tubular Glass division will be presenting a range of prefillable syringes, including its flagship RTF® sterile syringes at CPhI in Jakarta (Indonesia), 20-22 March 2013. Tubular glass is the input material for a comprehensive range of high quality pharmaceutical vials, ampoules and cartridges in numerous filling sizes and design variants.
At the upcoming edition of CPhI in Jakarta (Indonesia), 20-22 March 2013, Gerresheimer will be providing visitors with information about new glass and plastic packaging solutions for the pharmaceutical industry.
After acquiring a majority stake in the Indian companies Neutral Glass (April 2012) and Triveni (December 2012) Gerresheimer is ideally positioned to serve the fast-growing healthcare markets in South East Asia. It also has production facilities in Beijing, Dongguan, Shuangfeng and Zhenjiang where it manufactures glass and plastic primary packaging products for the Chinese market.
The Tubular Glass division is presenting a range of prefillable syringes, including its flagship RTF® sterile syringes. Tubular glass is the input material for a comprehensive range of high quality pharmaceutical vials, ampoules and cartridges in numerous filling sizes and design variants.
The Moulded Glass division manufactures high-quality injection and infusion bottles as well as dropper and tablet bottles of various types, shapes and sizes in glass categories I, II and III.
Gerresheimer is an internationally leading manufacturer of high-quality speciality products made of glass and plastic for the global pharma and healthcare industry, with a product portfolio ranging from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. The Group realizes revenues of around EUR 1.2 billion and has around 11,000 employees at 47 locations in Europe, North and South America and Asia.